Ingalls & Snyder’s InspireMD NSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding NSPR
Ingalls & Snyder's NSPR Position: Q3 2026 in Review
Ingalls & Snyder reduced its InspireMD (NSPR) stake by 1.7% in Q3 2026, selling an estimated $4.81K and leaving 362,550 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #402.
Ingalls & Snyder first reported a position in NSPR in Q3 2025 and has held it in 5 quarters since. The position peaked at $684K in Q4 2025. 27 funds tracked by Wall St. Rank hold NSPR as of Q3 2026.
- Ingalls & Snyder held 362,550 shares of InspireMD worth $242K as of Q3 2026.
- Ingalls & Snyder sold 6,250 InspireMD shares in Q3 2026, an estimated $4.81K.
- InspireMD made up 0.01% of Ingalls & Snyder's portfolio in Q3 2026, its #402 holding.
- Ingalls & Snyder first reported a position in InspireMD in Q3 2025 and has held it in 5 quarters since.
- Ingalls & Snyder's InspireMD position peaked at $684K in Q4 2025.
- 27 funds tracked by Wall St. Rank held InspireMD as of Q3 2026.
Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.